Related Experiment Video
Updated: Jul 2, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracerebral hemorrhage: medical treatment
1Istituto Auxologico Italiano, IRCCS, U. O. Cardiologia Ospedale San Luca, Via Spagnoletto 3, 20149, Milano, Italy. santalucia@auxologico.it
Insights
Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality. Early diagnosis and understanding prognostic indicators like hematoma size are crucial for patient outcomes.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Medicine
Background:
- Intracerebral hemorrhage (ICH) constitutes 10-30% of strokes, with significantly worse outcomes than ischemic stroke.
- ICH carries a high 30-day mortality rate (up to 50%), with many deaths occurring in the acute phase.
- Primary ICH (80%) stems from hypertension-related vessel rupture, while secondary ICH (20%) is linked to vascular issues, tumors, or anticoagulation.
Purpose of the Study:
- To emphasize the critical need for rapid recognition and diagnosis of ICH.
- To highlight the importance of identifying early prognostic indicators for patient management.
- To discuss the role of hematoma size as a key predictor of mortality and neurological decline.
Main Methods:
- Review of existing literature on intracerebral hemorrhage.
- Analysis of etiological classifications (primary vs. secondary ICH).
- Examination of prognostic factors, particularly hematoma size and expansion.
Main Results:
- Hematoma size is a primary predictor of 30-day mortality in ICH.
- Hematoma expansion strongly correlates with neurological deterioration.
- Blood pressure management is a key, though debated, medical approach.
Conclusions:
- Prompt ICH diagnosis and prognostic assessment are vital for timely intervention.
- Understanding predictors like hematoma size aids in planning patient care and anticipating progression.
- Ongoing research and clinical trials are exploring novel treatments for ICH.
Abstract:
Intracerebral hemorrhage (ICH) accounts for between 10% to 30% of first-ever strokes; outcomes are significantly worse than with ischemic stroke with a 30-day mortality rate up to 50%, furthermore, half of the deaths occur in the acute phase. Intracerebral hemorrhage (ICH) is classified as primary or secondary according to the underlying etiology. Primary ICH (about 80%) comes from the spontaneous rupture of small vessels more often in relation to long-standing or uncontrolled arterial hypertension and is generally located in the basal ganglia and internal capsula. Secondary ICH (about 20%) is often associated with vascular abnormalities, tumors, and anticoagulant therapy or coagulation disorders, more frequently located in cerebral lobes or subtentorial (cerebellum or pons). Rapid recognition and diagnosis of ICH as well as identification of early prognostic indicators are essential for planning the level of care and avoiding acute rapid progression during the first hours. Hematoma size has been identified as one of the most important predictors of 30-day mortality and its expansion is highly predictive of neurological deterioration. Blood pressure management remains, although controversial, the first-line medical approach along with possible new and effective treatments coming from the numerous between pilot and larger randomized medical trials for ICH completed in the past decade.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
